Manual of Clinical Microbiology, Volume 2Patrick R. Murray, Ellen Jo Baron ASM Press, 2003 - 2113 pagine Since its inaugural edition was published in 1970, the Manual of Clinical Microbiology has been hailed as the gold standard for excellence among clinical microbiology books. That tradition of quality continues with the publication of the new eighth edition. Greatly expanded and reorganized into two volumes, MCM is the definitive resource for the microbiology, epidemiology, and clinical significance of all clinically important bacteria, viruses, fungi, and parasites. This invaluable text provides all microbiologists, laboratorians, and infectious disease professionals with the authoritative reference for running an effective, state-of-the-art diagnostic laboratory. No other single resource offers extensive, up-to-date information to address both the practical and esoteric questions. MCM sets the standard for reliability and day-to-day utility as a reference work for all busy professionals in the diagnostic laboratory and infectious disease communities. Guiding the clinical microbiologist in the selection, performance, and interpretation of laboratory procedures, MCM focuses on the when and why of diagnostic procedures, as well as the how. It presents a direct approach to organizing information with thorough but concise treatments of all the major areas of microbiology, including new microbial discoveries, changing diagnostic methods, and emerging therapeutic challenges facing clinicians. |
Dall'interno del libro
Risultati 1-3 di 98
Pagina 1474
... assay that quan- titates HBV DNA concentrations ranging from 4.7 × 103 to 5.6 x 107 copies / ml . The assay requires as little as 50 μl of serum for the standard assay and 1 ml of serum for the ultrasensitive assay ( 25 , 51 ) . A ...
... assay that quan- titates HBV DNA concentrations ranging from 4.7 × 103 to 5.6 x 107 copies / ml . The assay requires as little as 50 μl of serum for the standard assay and 1 ml of serum for the ultrasensitive assay ( 25 , 51 ) . A ...
Pagina 1484
... assay performance were not statisti- cally significant . To address the high false - positive rate of the EIAs , particularly in low - risk populations , a strip immunoassay ( RIBA - 1 ; Chiron Corp. ) was developed as a supplemental ...
... assay performance were not statisti- cally significant . To address the high false - positive rate of the EIAs , particularly in low - risk populations , a strip immunoassay ( RIBA - 1 ; Chiron Corp. ) was developed as a supplemental ...
Pagina 1486
... assay was recently released but is not yet FDA approved ( Bayer VERSANT HCV RNA 3.0 assay [ Bayer Diagnostics ] ) . The bDNA - 3 has a much higher sensitivity than earlier bDNA assays . Refinements that contribute to the increased sensi ...
... assay was recently released but is not yet FDA approved ( Bayer VERSANT HCV RNA 3.0 assay [ Bayer Diagnostics ] ) . The bDNA - 3 has a much higher sensitivity than earlier bDNA assays . Refinements that contribute to the increased sensi ...
Sommario
SECTION VIII | 1201 |
CHAPIN REAGENTS STAINS MEDIA | 1202 |
Phenotypic and Chryseobacterium Moraxella and Other | 1204 |
Copyright | |
67 sezioni non visualizzate
Parole e frasi comuni
acid activity acute addition agents AIDS amplification analysis antibodies antigen antiviral appear assay associated blood cause cell culture cell lines Center chronic Clin clinical collected containing detection determined developed diagnosis dilution direct disease drug effects evaluation fluid gene genome genotype Health hepatitis herpes human hybridization identification immune important increase individuals infection influenza isolates laboratory levels major measles medium methods Microbiol molecular mutations negative occur patients performed plasma polymerase positive present primary primers probes procedures protein rabies rapid reaction reactive recent reference region replication reported resistance respiratory response rubella samples sensitivity sequence serologic serum specific specimens staining studies Table therapy tion tissue titers transmission transplant treatment United usually vaccine viral Virol virus virus infection viruses weeks Western blot